According to the report Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, published by Market Data Forecast, Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market is poised to reach USD 2.76 billion by 2020.
Attention deficit hyperactivity disorder (ADHD), is one of the most common neurological/psychiatric disorders among children and adolescents. ADHD is commonly observed in children (<12 years age) as compared to adolescents. ADHD is also described as hyperkinetic disorder/ attention deficit disorder or neuropsychiatric disorder. The exact cause for the ADHD is not clear but, expected to be resulted due to genetic factors and environmental influences. ADHD results in improper functioning of nervous system that led to attention deficit and hyperactivity/impulsiveness condition. ADHD is characterized by certain symptoms include easy distraction & striving to maintain focus on one task, unable to remember things, impatience, and being continuously in motion, among others. The symptoms of attention deficit hyperactivity disorder (ADHD) are controlled by different modalities such as medication (stimulants-amphetamines; non-stimulants-atomoxetine), psychotherapy (behavior therapy, cognitive behavioral therapy), and education/training (parent management training, family training).
Increasing involvements from public organizations, rising public conscious towards the better health conditions, and presence of effective therapeutics for the treatment of ADHD are driving the growth of attention deficit hyperactivity disorder therapeutics market in Europe. However, presence of stringent regulatory guidelines and high cost of the medication for ADHD are expected to restrain the growth of attention deficit hyperactivity disorder therapeutics market in Asia-Pacific.
Get a comprehensive overview of the ADHD Therapeutics Market: http://www.marketdataforecast.com/market-reports/asia-pacific-attention-deficit-hyperactivity-disorder-therapeutics-market-307/
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Drivers & Restraints
Get accurate market forecast and analysis on the ADHD Therapeutics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-attention-deficit-hyperactivity-disorder-therapeutics-market-307/request-sample
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Segmentation
By Medication Type
- Behavior therapy
- Cognitive Behavioral Therapy
- Interpersonal Psychotherapy
- Family Therapy
By Education or Training
- Parent management training
- Social skills training
- School-based interventions
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/asia-pacific-attention-deficit-hyperactivity-disorder-therapeutics-market-307/customize-report
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Overview
Growing healthcare industry, increasing initiatives from government to provide better treatment solutions for mental illness conditions, growing focus of foreign pharmaceutical companies on Asian market, presence of huge population, and rising number of mental disorders are driving the growth of attention deficit hyperactivity disorder therapeutics market in Asia-Pacific region. However, high cost pertaining to the treatment and limited adoption of ADHD therapeutics are restraining the growth of attention deficit hyperactivity disorder therapeutics market in Asia-Pacific region.
The ADHD market has been commanded by stimulant treatment, with just three affirmed non-stimulant medications endorsed that can’t rival stimulant medications as far as adequacy. Because of absence of confirmation for long term safe utilization of stimulants, non-stimulants are surfacing noticeably.
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Region-wise Outlook
On the basis of geographical areas, Asia-Pacific attention deficit hyperactivity disorder (ADHD) therapeutics market is segmented as Japan, China, India, Australia, and South Korea.
Key Questions Answered
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Key Players
The key players in attention deficit hyperactivity disorder (ADHD) therapeutics market such as, Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.), and Curemark, LLC. (U.S.).
Reasons to buy Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Report:
- Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
- Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
- A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the ADHD Segment:
Companion Diagnostics Market:
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases